DADC
GH icon

D.A. Davidson & Co’s Guardant Health GH Stock Holding History

D.A. Davidson & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Sell
12,526
-18,192
-59% -$1.98M 0.01% 754
2026
Q1 		$2.84M Buy
30,718
+12,866
+72% +$1.29M 0.02% 573
2025
Q4 		$1.82M Buy
17,852
+2,005
+13% +$179K 0.01% 692
2025
Q3 		$990K Sell
15,847
-23,466
-60% -$1.28M 0.01% 870
2025
Q2 		$2.05M Buy
39,313
+15,644
+66% +$699K 0.01% 602
2025
Q1 		$1.01M Sell
23,669
-18,711
-44% -$807K 0.01% 767
2024
Q4 		$1.29M Buy
42,380
+17,755
+72% +$499K 0.01% 684
2024
Q3 		$565K Sell
24,625
-1,920
-7% -$54.3K ﹤0.01% 966
2024
Q2 		$767K Sell
26,545
-1,150
-4% -$26.8K 0.01% 824
2024
Q1 		$571K Sell
27,695
-2,098
-7% -$45K 0.01% 942
2023
Q4 		$806K Buy
29,793
+5,568
+23% +$146K 0.01% 780
2023
Q3 		$718K Buy
24,225
+2,630
+12% +$92.5K 0.01% 787
2023
Q2 		$773K Buy
21,595
+10,426
+93% +$299K 0.01% 773
2023
Q1 		$262K Buy
+11,169
New +$319K ﹤0.01% 1136
2022
Q4 		– Sell
-6,908
Closed -$372K – 1346
2022
Q3 		$372K Buy
6,908
+764
+12% +$39.2K ﹤0.01% 921
2022
Q2 		$248K Buy
6,144
+364
+6% +$18K ﹤0.01% 1086
2022
Q1 		$383K Buy
5,780
+602
+12% +$41.2K ﹤0.01% 981
2021
Q4 		$518K Buy
5,178
+318
+7% +$32.9K 0.01% 869
2021
Q3 		$608K Buy
4,860
+348
+8% +$41.3K 0.01% 781
2021
Q2 		$560K Buy
4,512
+240
+6% +$32.3K 0.01% 800
2021
Q1 		$652K Buy
4,272
+601
+16% +$90.8K 0.01% 719
2020
Q4 		$473K Buy
3,671
+768
+26% +$88.4K 0.01% 734
2020
Q3 		$324K Buy
2,903
+267
+10% +$24.4K 0.01% 754
2020
Q2 		$214K Buy
+2,636
New +$212K ﹤0.01% 846

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

D.A. Davidson & Co's GH Position: Q2 2026 in Review

D.A. Davidson & Co reduced its Guardant Health (GH) stake by 59% in Q2 2026, selling an estimated $1.98M and leaving 12,526 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #754.

D.A. Davidson & Co first reported a position in GH in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.84M in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • D.A. Davidson & Co held 12,526 shares of Guardant Health worth $1.88M as of Q2 2026.
  • D.A. Davidson & Co sold 18,192 Guardant Health shares in Q2 2026, an estimated $1.98M.
  • Guardant Health made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #754 holding.
  • D.A. Davidson & Co first reported a position in Guardant Health in Q2 2020 and has held it in 24 quarters since.
  • D.A. Davidson & Co's Guardant Health position peaked at $2.84M in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.